Abnormal lipoproteins in the ANIT-treated rat: A transient and reversible animal model of intrahepatic cholestasis

Journal of Lipid Research

Volumn 37, Issue 5, 1996, Pages 1086-1098

  Chisholm, Jeffrey W ^a   Dolphin, Peter J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

naphthylisothiocyanate (ANIT); density gradient ultracentrifugation; electrophoresis; intrahepatic cholestasis; Lp X; rats

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; BILE ACID; BILIRUBIN; CHOLESTEROL; CHOLESTEROL ESTER; LIPOPROTEIN; LIPOPROTEIN LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ELECTROPHORESIS; ENZYME ACTIVITY; FEMALE; HYPOLIPOPROTEINEMIA; INTRAHEPATIC CHOLESTASIS; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RAT;

1-NAPHTHYLISOTHIOCYANATE; ANIMALS; CHOLESTASIS, INTRAHEPATIC; DISEASE MODELS, ANIMAL; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; LECITHIN ACYLTRANSFERASE DEFICIENCY; LIPOLYSIS; LIPOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0029939696     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Capizzo, F., and R. J. Roberts. 1971. α-Naphthylisothiocyanate (ANIT)-induced hepatotoxicity and disposition in various species. Toxicol. Appl. Pharmacol. 19: 176-187.
2. Goldfarb, S., E. J. Singer, and H. Popper. 1962. Experimental cholangitis due to alpha-naphthylisothiocyanate (ANIT). Am. J. Pathol. 40: 685-695.
3. Plaa, G. L., and B. G. Priestly. 1976. Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol. Rev. 28: 207-273.
4. Ungar, H., E. Moran, M. Eisner, and M. Eliakim. 1962. Rat intrahepatic biliary tract lesions from alpha-naphthylisothiocyanate. Arch. Pathol. 73: 427-435.
5. Desmet, V. J., B. Krstulovic, and B. Van Damme. 1968. Histochemical study of rat liver in α-naphthylisothiocyanate (ANIT)-induced cholestasis. Am. J. Pathol. 52: 401-421.
6. Kosser, D. C., P. C. Meunier, J. A. Handler, R. S. Sozio, and R. S. Goldstein. 1993. Temporal relationship of changes in hepatobiliary function and morphology in rats following α-naphthylisothiocyanate (ANIT) administration. Toxicol. Appl. Pharmacol. 119: 108-114.
7. El-Hawari, A. M., and G. A. Plaa. 1979. Impairment of hepatic mixed-function oxidase activity by α- and β-naphthylisothiocyanate: relationship to hepatotoxicity. Toxicol. Appl. Pharmacol. 48: 445-458.
8. Schaffner, F., H. H. Scharnbeck, F. Hutterer, H. Denk, H. A. Greim, and H. Popper. 1973. Mechanism of cholestasis. VII. α-Naphthylisothiocyanate-induced jaundice. Lab. Invest. 28: 321-331.
9. Plaa, G. L., L. A. Rogers, and J. R. Fouts. 1965. Effect of acute alpha-naphthylisothiocyanate administration on hepatic microsomal drug metabolism in the mouse. Proc. Soc. Exp. Biol. Med. 119: 1045-1048.
10. Becker, B. A., and G. A. Plaa. 1965. Quantitative and temporal delineation of various parameters of liver dysfunction due to α-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 7: 708-718.
11. Becker, B. A., and G. L. Plaa. 1965. The nature of α-naphthylisothiocyanate-induced cholestasis. Toxicol. Appl. Pharmacol. 7: 680-685.
12. Krell, H., H. Hoke, and E. Pfaff. 1982. Development of intrahepatic cholestasis by α-naphthylisothiocyanate in rats. Gastroenterology. 82: 507-514.
13. Katterman, V. R., and D. I. Wolfrum. 1970. Cholesterin-stoffwechsel und Lecithin-Cholesterin-Acyltransferase im Plasma bei experimenteller Hepatitis and Cholestase and der Ratte. Z. Clin. Chem. Klin. Biochem. 8: 413-419.
14. Cooper, A. D., and R. K. Ockner. 1974. Studies of hepatic cholesterol synthesis in experimental acute biliary obstruction. Gastroenterology. 66: 586-595.
15. Walli, A. K., and D. Seidel. 1984. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia: uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal inhuman fibroblasts, lymphocytes, and in the rat. J. Clin. Invest. 74: 867-879.
16. Mitamura, T. 1984. Alterations of high density lipoproteins in experimental intrahepatic cholestasis in the rat induced by administration of α-naphthylisothiocyanate. J. Biochem. 95: 29-36.
17. Felker, T. E., R. L. Hamilton, J. Vigne, and R. J. Havel. 1982. Properties of lipoproteins in blood plasma and liver perfusates of rats with cholestasis. Gastroenterology. 83: 652-663.
18. Calandra, S., M. J. Martin, M. J. O'Shea, and N. McIntyre. 1972. The effect of experimental biliary obstruction on the structure and lipid content of rat erythrocytes. Biochim. Biophys. Acta. 260: 424-432.
19. Kuksis, A., J. J. Myher, K. Geher, A. G. D. Hoffman, W. C. Breckenridge, G. J. L. Jones, and J. A. Little. 1978. Comparative determination of plasma cholesterol and triacylglycerol by automated gas-liquid chromatographic and Autoanalyzer methods. J. Chromatogr. 146: 393-412.
20. Chen, C-H., and J. J. Albers. 1982, Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J. Lipid Res. 23: 680-691.
21. Jauhiainen, M., and P. J. Dolphin. 1986. Human plasma lecithin-cholesterol acyltransferase: an elucidation of the catalytic mechanism. J. Biol. Chem. 261: 7032-7043.
22. Jackson, R. I., and L. R. MacLean. 1991. Human postheparin plasma lipoprotein lipase and hepatic triglyceride lipase. Methods Enzymol. 197: 339-345.
23. Nilsson-Ehle, P., and M. C. Schotz. 1976. A stable, radioactive substrate emulsion for the assay of lipoprotein lipase. J. Lipid Res. 17: 536-541.
24. Krul, E. S., and P. J. Dolphin. 1982. Isolated hepatocytes from hypercholesterolemic rats secrete discoidal lipoproteins. FEBS Lett. 139: 259-264.
25. Chapman, M. J., S. Goldstein, S. Lagrange, and P. M. Laplaud. 1981. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22: 339-356.
26. Markwell, M. A., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
27. Irwin, D., P. A. O'Looney, E. Quinet, and G. V. Vahouny. 1984. Application of SDS gradient polyacrylamide slab gel electrophoresis to analysis of apolipoprotein mass and radioactivity of rat lipoproteins. Atherosclerosis. 53: 163-172.
28. Asztalos, B. F., C. H. Sloop, L. Wong, and P. S. Roheim. 1993. Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apoA-I-containing subpopulations. Biochim. Biophys. Acta. 1169: 291-300.
29. Ritland, S., J. P. Blomhoff, and E. Gjone. 1973. Lecithin:cholesterol acyl-transferase and lipoprotein-X in liver disease. Clin. Chim. Acta. 49: 251-259.
30. Wengeler, H., H. Greten, and D. Seidel. 1970. Serum cholesterol esterification in liver disease. Combined determinations of lecithin:cholesterol acyltransferase and Lp-X. Eur. J. Clin. Invest. 2: 372-378.
31. Sabesin, S. M., L. B. Kuiken, and J. B. Ragland. 1975. Lipoprotein and lecithin:cholesterol acyltransferase changes in galaclosamine-induced rat liver injury. Science. 190: 1302-1304.
32. Manzato, E., R. Fellin, G. Baggio, S. Walch, W. Neubeck, and D. Seidel. 1976. Formation of lipoprotein-X: its relationship to bile compounds. J. Clin. Invest. 57: 1248-1260.
33. 3. J. Biol. Chem. 252: 2113-2120.
34. Breckenridge, W. C., G. Kakis, and A. Kuksis. 1979. Identification of lipoprotein X-like particles in rat plasma following Intralipid infusion. Can. J. Biochem. 57: 72-82.
35. Baumgartner, U., J. Scholmerich, P. Leible, and E. H. Farthmann. 1992. Cholestasis, metabolism and biliary lipid secretion during perfusion of rat liver with different bile salts. Biochim. Biophys. Acta. 1125: 142-149.
36. Quarfordt, S. H., H. Oelschlaeger, W. R. Krigbaum, L. Jakoi, and R. Davis. 1973. Effect of biliary obstruction on canine plasma and biliary lipids. Lipids. 8: 522-530.
37. Guerin, M., P. J. Dolphin, and M. J. Chapman. 1993. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis. 104: 195-212.
38. Torsvik, H., K. Berg, H. N. Magnani, J. McConathy, P. Alaupovic, and E. Gjone. 1972. Identification of the abnormal cholestatic lipoprotein (Lp-X) in familial lecithin:cholesterol acyltransferase deficiency. FEBS Lett. 24: 165-168.
39. Tashiro, T., Y. Mashima, H. Yamamori, K. Horibe, M. Nishizawa, M. Sanada, and K. Okui. 1991. Increased lipoprotein-X causes hyperlipidemia during intravenous administration of 10% fat emulsion in man. J. Parenter. Enteral Nutr. 15: 546-550.
40. Ritland, S., and A. Bergen. 1975. Plasma concentration of lipoprotein-X in experimental bile obstruction. Scand. J. Gastroenterol. 10: 17-24.
41. Clifton, P. M., P. J. Barter, and A. M. Mackinnon. 1988. High density lipoprotein particle size distribution in subjects with obstructive jaundice. J. Lipid Res. 29: 121-135.
42. Seidel, D., H. Greten, H. P. Geisen, H. Wengeler, and H. Wieland. 1972. Further aspects on the characterization of high and very low density lipoproteins in patients with liver disease. Eur. J. Clin. Invest. 2: 359-364.
43. Larsson, B., and A. Nilsson. 1980. Inhibition of chylomicron remnant uptake in cholestatic rat. Scand. J. Gastroenterol. 15: 959-967.
44. Muller, P., R. Fellin, J. Lamprecht, B. Agostini, H. Wieland, W. Rost, and D. Seidel. 1974. Hypertriglyceridemia secondary to liver disease. Eur. J. Clin. Invest. 4: 419-428.